A phase II trial of the histone deacetylase inhibitor belinostat (PXD101) in patients with platinum resistant epithelial ovarian tumors and micropapillary/borderline (LMP) ovarian tumors. A PMH phase II consortium trial Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Mackay, H
  • Hirte, Holger
  • Covens, A
  • MacAlpine, K
  • Wang, L
  • Tsao, MS
  • Pan, J
  • Zwiebel, JA
  • Oza, AM

publication date

  • May 20, 2008